Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
EMA clears compassionate use of Gilead’s remdesivir for COVID-19
Pharmaforum
Tue, 04/7/20 - 07:42 pm
Europe
EMA
Gilead Sciences
COVID-19
remdesivir
Gilead to lean on Second Genome's microbiome work in $38M research pact
BioPharma Dive
Mon, 04/6/20 - 09:31 pm
Gilead Sciences
Second Genome
microbiome
R&D
Gilead Speeds Manufacture of Experimental COVID-19 Drug, Doesn’t Plan to Charge
BioSpace
Mon, 04/6/20 - 10:38 am
Gilead Sciences
remdesivir
COVID-19
Gilead Has Treated More Than 1,700 COVID-19 Patients With Remdesivir
Motley Fool
Mon, 04/6/20 - 10:24 am
Gilead Sciences
COVID-19
remdesivir
Gilead ramps up production of experimental Covid-19 treatment amid criticism over access
Stat
Sun, 04/5/20 - 02:32 pm
Gilead Sciences
COVID-19
remdesivir
drug manufacturing
EMA Recommends Remdesivir for Treatment of COVID-19 Under Compassionate-Use Rules
Motley Fool
Fri, 04/3/20 - 06:32 pm
Gilead Sciences
Europe
COVID-19
remdesivir
A Covid-19 threat to business acquisitions
EP Vantage
Thu, 04/2/20 - 11:57 am
COVID-19
M&A
AbbVie
Allergan
Arya Sciences
Immatics
AcelRx
Tetraphase
Gilead Sciences
Forty Seven
Thermo Fisher
Stryker
Wright Medical
Motion denied: Gilead still on the hook for $1.5B in damages over CAR-T patent dispute with Bristol Myers Squibb
Endpoints
Wed, 04/1/20 - 09:33 am
Gilead Sciences
CAR-T
Bristol-Meyers Squibb
Juno Therapeutics
patents
Gilead Sciences Expects Coronavirus Drug Data in Coming Weeks, Expands Access
Yahoo/SmarterAnalyst
Sun, 03/29/20 - 09:00 pm
Gilead Sciences
remdesivir
COVID-19
WHO Initiates a Clinical Trial for Four Drugs in Fight Against COVID-19
BioSpace
Sat, 03/28/20 - 11:22 pm
WHO
Norway
Spain
clinical trials
COVID-19
hydroxychloroquine
Gilead Sciences
remdesivir
Lopinavir
ritonavir
For Gilead, Its Coronavirus Treatment Is Icing on the Cake
Motley Fool
Fri, 03/27/20 - 10:56 am
Gilead Sciences
remdesivir
COVID-19
KTE-X19
magrolimab
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
Thu, 03/26/20 - 10:38 am
JNJ
Novartis
Boehringer Ingelheim
Biomerieux
Eisai
Eli Lilly
Gilead Sciences
GSK
Merck
Merck KGaA
Pfizer
Sanofi
R&D
COVID-19
diagnostics
vaccines
Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19
Motley Fool
Wed, 03/25/20 - 11:59 pm
Gilead Sciences
remdesivir
FDA
orphan drugs
COVID-19
Galapagos CEO talks next steps as coronavirus stalls the biotech's top drug
BioPharma Dive
Wed, 03/25/20 - 11:41 pm
Galapagos
Gilead Sciences
filgotinib
rheumatoid arthritis
FDA
COVID-19
When might experimental drugs to treat Covid-19 be ready? A forecast
Stat
Tue, 03/24/20 - 10:53 am
COVID-19
coronaviruses
drug development
remdesivir
Gilead Sciences
vaccines
antibodies
Gilead pauses access to experimental Covid-19 drug due to ‘overwhelming demand’
Stat
Sun, 03/22/20 - 11:45 pm
Gilead Sciences
remdesivir
COVID-19
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
Motley Fool
Sat, 03/21/20 - 10:59 pm
COVID-19
Gilead Sciences
Mylan
Bayer
chloroquine
hydroxychloroquine
Fujifilm
Avigan
Kevzara
Actemra
Regeneron
Sanofi
Roche
FDA Approves Gilead’s Epclusa for Children with Hepatitis C
BioSpace
Fri, 03/20/20 - 10:43 am
Epclusa
hepatitis C
Gilead Sciences
FDA
pediatric
FDA chief highlights Gilead drug’s availability under compassionate use for Covid-19
MedCity News
Fri, 03/20/20 - 10:34 am
FDA
Stephen Hahn
remdesivir
compassionate use guidelines
Gilead Sciences
COVID-19
Can This American Biotech Company Save the Global Economy?
Motley Fool
Mon, 03/16/20 - 10:46 am
Gilead Sciences
remdesivir
COVID-19
biotech
coronaviruses
Pages
« first
‹ previous
…
18
19
20
21
22
23
24
25
26
…
next ›
last »